Differentiating COVID-associated myocarditis from other Diseases: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 10: Line 10:
==Differential Diagnosis==
==Differential Diagnosis==


COVID-19-associated myocarditis must be differentiated from [[pneumonia]], [[acute respiratory distress syndrome]], [[heart failure]], and [[pulmonary embolism]].
COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, elevated cardiac [[biomarkers]], [[ventricular dysfunction]] such as  including [[COVID-19-associated myocardial infarction|Acute Coronary Syndrome]], [[COVID-19-associated stress cardiomyopathy|Stress-induced cardiomyopathy]] ([[Takotsubo cardiomyopathy]]) and [[COVID-19-associated heart failure|Heart failure]].
 
<small>
<small>
{|
{|
Line 31: Line 30:
!<small>Echocardiography</small>
!<small>Echocardiography</small>
!<small>CT scan and CMR</small>  
!<small>CT scan and CMR</small>  
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated myocarditis]]
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |
*[[Pericardial effusion]] may be detectable
| style="background: #F5F5F5; padding: 5px;" |
* Non-specific:may show nonspecific ST-T abnormalities, [[sinus tachycardia]] and [[conduction abnormalities]] (such as bundle-branch blocks or atrioventricular conduction delays)
| style="background: #F5F5F5; padding: 5px;" |
*Non-specific: In [[fulminant myocarditis]], cardiac chamber sizes are usually normal with an increased septal thickness (secondary to acute myocardial edema), whereas in acute [[myocarditis]] marked left ventricular dilation and normal wall thickness might be seen.
*[[Pericardial effusion]] may be be seen.
| style="background: #F5F5F5; padding: 5px;" |
*CMR: T2-weighted edema imaging shows the presence of “acute myocardial inflammation”. "[[Late gadolinium enhancement (LGE)]] imaging” can demonstrate myocardial damage.
| style="background: #F5F5F5; padding: 5px;" | Increased cardiac [[troponin]]s level
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated heart failure|COVID-19-associated heart failure]]
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated heart failure|COVID-19-associated heart failure]]
Line 88: Line 105:
*CT: Bilateral [[ground-glass opacities]]
*CT: Bilateral [[ground-glass opacities]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated myocarditis]]
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |
*[[Pericardial effusion]] may be detectable
| style="background: #F5F5F5; padding: 5px;" |
* Non-specific:may show nonspecific ST-T abnormalities, [[sinus tachycardia]] and [[conduction abnormalities]] (such as bundle-branch blocks or atrioventricular conduction delays)
| style="background: #F5F5F5; padding: 5px;" |
*Non-specific: In [[fulminant myocarditis]], cardiac chamber sizes are usually normal with an increased septal thickness (secondary to acute myocardial edema), whereas in acute [[myocarditis]] marked left ventricular dilation and normal wall thickness might be seen.
*[[Pericardial effusion]] may be be seen.
| style="background: #F5F5F5; padding: 5px;" |
*CMR: T2-weighted edema imaging shows the presence of “acute myocardial inflammation”. "[[Late gadolinium enhancement (LGE)]] imaging” can demonstrate myocardial damage.
| style="background: #F5F5F5; padding: 5px;" | Increased cardiac [[troponin]]s level
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated pulmonary embolism]]
|style="background: #DCDCDC; padding: 5px; text-align: center;" |[[COVID-19-associated pulmonary embolism]]

Revision as of 08:00, 24 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mounika Reddy Vadiyala, M.B.B.S.[2]


Overview

COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, elevated cardiac biomarkers, ventricular dysfunction such as including Acute Coronary Syndrome, Stress-induced cardiomyopathy (Takotsubo cardiomyopathy) and Heart failure.

Differential Diagnosis

COVID-19-associated myocarditis must be differentiated from other causes of dyspnea and chest pain, elevated cardiac biomarkers, ventricular dysfunction such as including Acute Coronary Syndrome, Stress-induced cardiomyopathy (Takotsubo cardiomyopathy) and Heart failure.

Diseases Symptoms Physical Examination Diagnostic tests Other Findings
Dyspnea on Exertion Chest Pain Hemoptysis Fever Tachypnea Tachycardia Chest X-ray ECG Echocardiography CT scan and CMR
COVID-19-associated myocarditis -
  • Non-specific: In fulminant myocarditis, cardiac chamber sizes are usually normal with an increased septal thickness (secondary to acute myocardial edema), whereas in acute myocarditis marked left ventricular dilation and normal wall thickness might be seen.
  • Pericardial effusion may be be seen.
  • CMR: T2-weighted edema imaging shows the presence of “acute myocardial inflammation”. "Late gadolinium enhancement (LGE) imaging” can demonstrate myocardial damage.
Increased cardiac troponins level
COVID-19-associated heart failure - - Increased NT-proBNP and cardiac troponins levels
COVID-19-associated pneumonia ✔ (Pleuritic) ✔ (Usually high)
  • Prolonged PR interval
  • Transient T wave inversions
- Increased inflammatory markers, including ESR, hs-CRP
COVID-19-associated acute respiratory distress syndrome - -
  • Signs of RV dysfunction/RV dilatation may be seen.
-
COVID-19-associated pulmonary embolism ✔ (Usually sudden-onset) ✔ (Pleauritic) ✔ (If massive PE) ✔ (Low-grade)
  • Non-specific:may show S1Q3T3 pattern
  • May show signs of RV strain, Rv dilatation, Rv dysfunction (if large PE)
  • On CT angiography: Intra-luminal filling defect
  • On MRI: Narrowing of involved vessel
  • No contrast seen distal to obstruction
  • Polo-mint sign (partial filling defect surrounded by contrast)


References